|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,653 GBX | +0.76% |
|
+3.38% | +13.98% |
| Apr. 25 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
| Apr. 25 | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
March 21 (Reuters) - GSK plc:
* GSK ANNOUNCES CAP OF $35 PER MONTH ON U.S. PATIENT OUT-OF-POCKET COSTS FOR ITS ENTIRE PORTFOLIO OF ASTHMA AND COPD INHALERS
* GSK - PROGRAM IS WIDE REACHING AND WILL BE IMPLEMENTED NO LATER THAN JANUARY 1, 2025 Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +13.98% | 84.13B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
GSK PLC 
